23,800 Shares in Alignment Healthcare, Inc. $ALHC Purchased by Handelsbanken Fonder AB

Handelsbanken Fonder AB bought a new stake in shares of Alignment Healthcare, Inc. (NASDAQ:ALHC) in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 23,800 shares of the company’s stock, valued at approximately $333,000.

Other large investors have also added to or reduced their stakes in the company. Invesco Ltd. increased its holdings in shares of Alignment Healthcare by 1,415.7% during the first quarter. Invesco Ltd. now owns 1,875,790 shares of the company’s stock valued at $34,927,000 after acquiring an additional 1,752,033 shares in the last quarter. Vanguard Group Inc. grew its holdings in shares of Alignment Healthcare by 13.2% during the first quarter. Vanguard Group Inc. now owns 11,113,896 shares of the company’s stock valued at $206,941,000 after buying an additional 1,295,825 shares during the last quarter. 8 Knots Management LLC increased its position in shares of Alignment Healthcare by 28.9% during the first quarter. 8 Knots Management LLC now owns 4,715,472 shares of the company’s stock valued at $87,802,000 after acquiring an additional 1,056,777 shares in the last quarter. Voya Investment Management LLC raised its holdings in Alignment Healthcare by 408.3% in the 1st quarter. Voya Investment Management LLC now owns 1,293,414 shares of the company’s stock worth $24,083,000 after acquiring an additional 1,038,940 shares during the last quarter. Finally, Assenagon Asset Management S.A. lifted its position in Alignment Healthcare by 124.8% in the 2nd quarter. Assenagon Asset Management S.A. now owns 1,869,035 shares of the company’s stock valued at $26,166,000 after acquiring an additional 1,037,638 shares in the last quarter. Hedge funds and other institutional investors own 86.19% of the company’s stock.

Alignment Healthcare Stock Performance

Shares of NASDAQ ALHC opened at $19.40 on Monday. Alignment Healthcare, Inc. has a 12-month low of $10.18 and a 12-month high of $21.06. The firm has a market capitalization of $3.88 billion, a price-to-earnings ratio of -161.63 and a beta of 1.16. The company has a current ratio of 1.61, a quick ratio of 1.61 and a debt-to-equity ratio of 1.99. The firm has a 50 day moving average of $17.22 and a 200 day moving average of $15.55.

Alignment Healthcare (NASDAQ:ALHC) last posted its quarterly earnings data on Thursday, October 30th. The company reported $0.02 EPS for the quarter, topping the consensus estimate of ($0.01) by $0.03. Alignment Healthcare had a negative return on equity of 16.23% and a negative net margin of 0.57%.The firm had revenue of $993.70 million for the quarter, compared to the consensus estimate of $980.90 million. During the same quarter last year, the company earned ($0.14) earnings per share. The business’s revenue for the quarter was up 43.5% compared to the same quarter last year. Alignment Healthcare has set its FY 2025 guidance at EPS. Q4 2025 guidance at EPS. On average, research analysts anticipate that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of research analysts have recently issued reports on the company. UBS Group upped their price target on Alignment Healthcare from $17.00 to $18.00 and gave the company a “neutral” rating in a report on Friday, October 31st. JPMorgan Chase & Co. upgraded shares of Alignment Healthcare from a “neutral” rating to an “overweight” rating and upped their target price for the company from $18.00 to $20.00 in a research note on Monday, November 24th. Barclays lifted their price target on shares of Alignment Healthcare from $13.00 to $18.00 and gave the stock an “equal weight” rating in a research note on Friday, October 31st. Zacks Research cut shares of Alignment Healthcare from a “strong-buy” rating to a “hold” rating in a report on Tuesday, October 28th. Finally, Wall Street Zen upgraded shares of Alignment Healthcare from a “hold” rating to a “buy” rating in a report on Saturday, November 8th. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, three have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $20.05.

Insider Buying and Selling at Alignment Healthcare

In related news, President Dawn Christine Maroney sold 215,662 shares of the stock in a transaction dated Wednesday, September 10th. The shares were sold at an average price of $16.41, for a total value of $3,539,013.42. Following the sale, the president directly owned 1,797,237 shares of the company’s stock, valued at $29,492,659.17. This represents a 10.71% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Atlantic (Aln Hlth) L. General sold 6,246,096 shares of the company’s stock in a transaction on Wednesday, September 17th. The shares were sold at an average price of $16.01, for a total value of $99,999,996.96. Following the completion of the transaction, the director directly owned 24,596,079 shares in the company, valued at $393,783,224.79. This trade represents a 20.25% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders sold 7,582,116 shares of company stock worth $122,276,938. Company insiders own 6.60% of the company’s stock.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.